FDA inspection
Luster Products Inc: FDA inspection ending Sep 13, 2024
FDA inspection 1249263 · Official Action Indicated (OAI) · Chicago, IL
Key facts
| Inspection ID | 1249263 |
|---|---|
| Firm | Luster Products Inc |
| FEI number | 1417123 |
| Address | 1104 W 43rd St |
| City | Chicago |
| State | IL |
| ZIP | 60609 |
| Country | United States |
| Fiscal year | 2024 |
| Inspection end date | Sep 13, 2024 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data